Pharmaceuticals Sector
Shaping up to a Changing Industry 

Sales 2008: EUR 2.7 billion
REBIT 2008: EUR 509 million
9 660 employees

Therapeutic fields
Integrated franchises (R&D and commercial)
• Cardiometabolics (dyslipidemia, type 2 diabetes, acute heart failure, diabetic nephropathy, pulmonary hypertension, atherosclerosis)
• Neuroscience (psychosis, Parkinson’s disease, traumatic brain injury, bipolar disorder)
• Niches in flu vaccines and pancreatic enzymes
Commercial franchises
• Gastroenterology
• Women’s and men’s health

Strategic priorities (2010)
• REBIT: EUR 640 million
• Operating margin*: >/=20%
• Efficiency improvements: EUR 300 million of annual synergies
• Investment focused on R&D

More about the Pharmaceuticals Sector

Chemicals Sector
Weather the Storm, Looking Ahead
 
Sales 2008: EUR 238 million
REBIT* 2008: EUR 345 million
8 966 employees

4 clusters
Minerals
• Soda ash and derivatives (bicarbonate)
• Advanced Functional Minerals
Electrochemistry, fluorinated products
• Electrochemicals and derivatives (caustic soda, epichlorohydrin)
• Fluorinated products
Oxygen
• Hydrogen peroxide
• Persalts
Organic (Molecular Solutions)
 
Strategic priorities
• Intensifying our geographic expansion
• Pursuing technological innovation
• Growth in specialties (mainly bicarbonate and fluorinated and organic specialties)
• Competitiveness

More about the Chemicals Sector

Plastics Sector
Robust and Ready 

Sales 2008: EUR 3.7 billion
REBIT 2008: EUR 264 million
8 816 employees

2 clusters
Specialties
• Specialty Polymers (high and ultra-high performance polymers like fluorinated Polymers, elastomers and fluids, barrier materials, polyarylamides, polysulfones, high performance polyamides, liquid crystal polymers)
• Inergy Automotive Systems (50/50 joint venture with Plastic Omnium)
Vinyls
• Vinyls (integrated electrolysis chain, VCM (monomer), PVC (polymer) and PVC compounds)
• Pipelife (50/50 joint venture with Wienerberger)

Strategic priorities
• Permanently reinforcing the robustness of our businesses;
• Focusing on:
– society’s fundamental, long-term needs;
– specifi c attractive growth regions;
• Accelerating growth by taking advantage of opportunities
linked to materials sciences;
• Keeping innovation and R&D as absolute priorities.

More about the Plastics Sector